Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 104, Issue 14, Pages 1068-1079
Publisher
Oxford University Press (OUP)
Online
2012-07-06
DOI
10.1093/jnci/djs261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of a breast cancer multidisciplinary team (MDT): a prospective study
- (2011) A. Balakrishnan et al. ANNALS OF ONCOLOGY
- Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer
- (2011) Jessica F. Partin et al. ANNALS OF SURGICAL ONCOLOGY
- Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
- (2011) Valesca P. Retèl et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
- (2011) Gong Tang et al. BREAST CANCER RESEARCH AND TREATMENT
- The Effect of Oncotype DX Recurrence Score on Treatment Recommendations for Patients with Estrogen Receptor-Positive Early Stage Breast Cancer and Correlation with Estimation of Recurrence Risk by Breast Cancer Specialists
- (2011) J. E. Joh et al. ONCOLOGIST
- US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer
- (2011) John Hornberger et al. Journal of Oncology Practice
- Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature
- (2010) Stella Mook et al. ANNALS OF SURGICAL ONCOLOGY
- Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patients
- (2010) Georg Kunz ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03)
- (2010) Masahide Kondo et al. BREAST CANCER RESEARCH AND TREATMENT
- Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
- (2010) Robert J. Paridaens et al. BREAST CANCER RESEARCH AND TREATMENT
- The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
- (2010) Michael Knauer et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population
- (2010) Masakazu Toi et al. CANCER
- Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
- (2010) Valesca P. Retèl et al. EUROPEAN JOURNAL OF CANCER
- Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population
- (2010) M. Ishitobi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
- (2010) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
- (2010) Shelly S. Lo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
- (2010) D. T. Tsoi et al. ONCOLOGIST
- Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
- (2010) Shmuel H. Klang et al. VALUE IN HEALTH
- The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
- (2009) S. Mook et al. ANNALS OF ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
- (2009) Marieke E. Straver et al. BREAST CANCER RESEARCH AND TREATMENT
- An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom
- (2009) H E Campbell et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Multidisciplinary Team Adjuvant Therapy Decision Making and Adjuvant! Online
- (2009) V. Nowak et al. CLINICAL ONCOLOGY
- Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
- (2009) S. Mook et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
- (2009) Kyoko Yorozuya et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The influence of a Gene expression profile on breast cancer decisions
- (2009) Leonard R. Henry et al. JOURNAL OF SURGICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study
- (2009) Stella Mook et al. LANCET ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
- (2009) Foluso O Ademuyiwa et al. MODERN PATHOLOGY
- Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
- (2008) Juhi Asad et al. AMERICAN JOURNAL OF SURGERY
- Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature
- (2008) Andrew Tutt et al. BMC CANCER
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
- Validation of 70-gene prognosis signature in node-negative breast cancer
- (2008) J. M. Bueno-de-Mesquita et al. BREAST CANCER RESEARCH AND TREATMENT
- Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic Subclassification
- (2008) L. R. Webster et al. CLINICAL CANCER RESEARCH
- Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
- (2008) B. S. Wittner et al. CLINICAL CANCER RESEARCH
- Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials
- (2008) D. T. Ross et al. CLINICAL CANCER RESEARCH
- A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer
- (2008) X.-J. Ma et al. CLINICAL CANCER RESEARCH
- Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
- (2008) Jo Anne Zujewski et al. Future Oncology
- Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
- (2008) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
- (2008) J. S. Ross et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More